Holen Sie sich die Stockscreener-App
0.8451
6.05%
-0.0495
Handel nachbörslich:
.85
0.0049
+0.58%
Schlusskurs vom Vortag:
$0.8946
Offen:
$0.8946
24-Stunden-Volumen:
1.61M
Relative Volume:
1.23
Marktkapitalisierung:
$83.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-93.61M
KGV:
-0.4005
EPS:
-2.11
Netto-Cashflow:
$-71.16M
1W Leistung:
-4.49%
1M Leistung:
+5.82%
6M Leistung:
-8.45%
1J Leistung:
-42.23%
1-Tages-Spanne:
$0.84
$0.8946
1-Wochen-Bereich:
$0.84
$0.9298
52-Wochen-Spanne:
$0.561
$1.73
Immunic Inc Stock (IMUX) Company Profile
Firmenname
Immunic Inc
Sektor
Branche
Telefon
(332) 255-9818
Adresse
1200 AVENUE OF THE AMERICAS, NEW YORK
Vergleichen Sie IMUX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.8451 | 88.25M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-25 | Eingeleitet | William Blair | Outperform |
| 2024-11-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-27 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-04-15 | Eingeleitet | Aegis Capital | Buy |
| 2021-03-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-07 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-20 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-06-05 | Eingeleitet | Wedbush | Outperform |
| 2020-05-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-25 | Eingeleitet | ROTH Capital | Buy |
| 2019-07-11 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Immunic Inc Aktie (IMUX) Neueste Nachrichten
Price momentum metrics for Immunic Inc. explainedJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
Will Immunic Inc. stock see PE expansionWeekly Trend Report & Capital Efficiency Focused Strategies - newser.com
Why Immunic Inc. stock could outperform in 2025Stop Loss & Daily Entry Point Trade Alerts - newser.com
Detecting price anomalies in Immunic Inc. with AIJuly 2025 Institutional & Expert Approved Trade Ideas - newser.com
Immunic targeting mental and physical challenges facing MS patientsICYMI - Proactive financial news
Can Immunic Inc. recover in the next quarterEarnings Trend Report & Weekly High Conviction Ideas - newser.com
Immunic marks World Mental Health Day, highlighting the mental consequence for MS patients - Proactive financial news
Why Immunic Inc. (10VA) stock fits value portfolios2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Why Immunic Inc. (10VA) stock benefits from AI revolutionProduct Launch & Verified Momentum Stock Alerts - newser.com
Comparing Immunic Inc. in custom built stock radarsJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - newser.com
Immunic (NASDAQ:IMUX) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Immunic Presents Promising Phase 2 Trial Results - MSN
Immunic receives notice of allowance for vidofludimus calcium patent - MSN
Applying chart zones and confluence areas to Immunic Inc.Market Performance Report & Free Fast Entry Momentum Trade Alerts - newser.com
Is Immunic Inc. (10VA) stock positioned for secular growthQuarterly Portfolio Report & Daily Volume Surge Signals - newser.com
Chart overlay techniques for tracking Immunic Inc.Profit Target & Risk Controlled Stock Alerts - newser.com
Risk adjusted return profile for Immunic Inc. analyzed2025 Pullback Review & Expert Curated Trade Ideas - newser.com
Using data tools to time your Immunic Inc. exitEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Why Immunic Inc. stock is favored by top institutionsPortfolio Value Summary & Long-Term Growth Plans - newser.com
Using data models to predict Immunic Inc. stock movementGold Moves & Growth Focused Stock Pick Reports - newser.com
Is Immunic Inc. stock ready for a breakout2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
How to read the order book for Immunic Inc.Earnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Can Immunic Inc. stock sustain institutional interestGDP Growth & Weekly Top Gainers Trade List - newser.com
Can momentum traders help lift Immunic Inc.Earnings Growth Report & Weekly Breakout Stock Alerts - newser.com
Positive Signs As Multiple Insiders Buy Immunic Stock - Yahoo Finance
Chardan Capital Estimates Immunic FY2026 Earnings - MarketBeat
What earnings revisions data tells us about Immunic Inc.Weekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Immunic to Participate in Scientific and Investor Conferences in October - The Malaysian Reserve
Finanzdaten der Immunic Inc-Aktie (IMUX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immunic Inc-Aktie (IMUX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
| Rudick Richard Alan | Director |
Nov 12 '24 |
Buy |
1.15 |
87,300 |
100,369 |
87,300 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):